Advertisement

European Journal of Trauma and Emergency Surgery

, Volume 44, Issue 5, pp 787–793 | Cite as

Preoperative decolonization to reduce infections in urgent lower extremity repairs

  • Daniel S. Urias
  • Merin Varghese
  • Thomas Simunich
  • Shawna Morrissey
  • Russell Dumire
Original Article

Abstract

Purpose

Medical implants and surgical site infections (SSIs) can be a burden on both patients and healthcare systems with a significant rise in morbidity, mortality and costs. Preoperatively, our practice of a chlorohexidine gluconate (CHG) washcloth bath or solution shower was supplemented with nasal painting using povidone-iodine skin and nasal antiseptic (PI-SNA). We sought to measure the effectiveness in reducing SSIs in patients undergoing repair of lower extremity fractures.

Methods

A retrospective review of trauma patients undergoing orthopedic operations conducted at Conemaugh Memorial Medical Center from 10/1/2012 through 9/30/2016. The intervention period was 10/1/2014 to 9/30/2016 which included the addition of nasal painting with PI-SNA preoperatively. All patients were followed for 1 year prior to January 2013 and 30 or 90 days thereafter for the development of a SSI.

Results

The pre-intervention group consisted of 930 cases with a 1.1% infection rate (10 SSIs). The intervention group consisted of 962 cases with a 0.2% infection rate (2 SSIs). This observed difference was statistically significant (P = 0.020).

Conclusions

This retrospective review of a methicillin-resistant Staphylococcus aureus decolonization protocol using CHG bath/shower and PI-SNA nasal painting revealed a significant decrease in the infection rate of patients undergoing lower extremity fracture repairs. We recommend its use without contraindications, but recognize that additional investigations are necessary.

Keywords

MRSA Fractures Surgical site infection Trauma Povidone-iodine Decolonization 

Notes

Acknowledgements

We thank Lisa Hoegg RN, BSN, CIC, CPHQ and the Department of Infection Prevention for collecting data and championing the implementation and adherence of the protocol.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

Conflict of interest

Daniel S. Urias, Merin Varghese, Thomas Simunich, Shawna Morrissey and Russell Dumire have no conflict of interest to declare.

Informed consent

Informed consent was not obtained as this was a retrospective study and only minimal personal health information (PHI) was collected. Following completion of data extraction, the data were de-identified with no link remaining to any PHI, and each case was randomly assigned a randomly generated study subject identification number.

References

  1. 1.
    Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care associated infections. External web site icon. N Engl J Med. 2014;370:119–208.CrossRefGoogle Scholar
  2. 2.
    Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital infection control practices advisory committee. Infect Control Hosp Epidemiol. 1999;20:250–78 (quiz 279–80).CrossRefGoogle Scholar
  3. 3.
    Surgical site infection (SSI) event. https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf. Accessed 10 Sep 2017.
  4. 4.
    Highlighted NHSNJ January 2013 patient safety component (PSC) manual updates. https://www.cdc.gov/nhsn/PDFs/Newsletters/January-2013-PSC-Updates.pdf. Accessed 10 Sep 2017.
  5. 5.
    Berríos-Torres SI. Surgical site infection (SSI) toolkit activity C: ELC prevention collaboratives. Division of healthcare quality promotion. Centers for disease control and prevention. http://www.cdc.gov/HAI/pdfs/toolkits/SSI_toolkit021710SIBT_revised.pdf. Accessed 13 Nov 2015.
  6. 6.
    Jernigan J, Kallen A. Methicillin-resistant Staphylococcus aureus (MRSA) infections. Activity C: ELC prevention collaboratives. Division of healthcare quality promotion. Centers for disease control and prevention. http://www.cdc.gov/HAI/pdfs/toolkits/MRSA_toolkit_white_020910_v2.pdf. Accessed 13 Nov 2015.
  7. 7.
    Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National healthcare safety network at the centers for disease control and prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011.CrossRefGoogle Scholar
  8. 8.
    Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28(9):1047–53.CrossRefGoogle Scholar
  9. 9.
    Anderson DJ, Podgorny K, Berríos-Torres SI, Bratzler DW, Dellinger EP, Greene L, Nyquist AC, Saiman L, Yokoe DS, Maragakis LL, Kaye KS. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(6):605–27.CrossRefGoogle Scholar
  10. 10.
    Schweizer ML, Chiang HY, Septimus E, Moody J, Braun B, Hafner J, Ward MA, Hickok J, Perencevich EN, Diekema DJ, Richards CL, Cavanaugh JE, Perlin JB, Herwaldt LA. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA. 2015;313 (21):2162–71.CrossRefGoogle Scholar
  11. 11.
    Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9–17.CrossRefGoogle Scholar
  12. 12.
    Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ, Spies-van Rooijen NH. Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1260 historical controls. Acta Orthop Scand. 1998;69(4):412–4.CrossRefGoogle Scholar
  13. 13.
    Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg. 2001;71(5):1572–8.CrossRefGoogle Scholar
  14. 14.
    Ramos N, Skeete F, Haas JP, Hutzler L, Slover J, Phillips M, Bosco J. Surgical site infection prevention initiative: patient attitude and compliance. Bull NYU Hosp Jt Dis. 2011;69(4):312–5.PubMedGoogle Scholar
  15. 15.
    Phillips M, Rosenberg A, Shopsin B, Cuff G, Skeete F, Foti A, Kraemer K, Inglima K, Press R, Bosco J. Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol. 2014;35(7):826 – 32.CrossRefGoogle Scholar
  16. 16.
    Anderson MJ, David ML, Scholz M, Bull SJ, Morse D, Hulse-Stevens M, Peterson ML. Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares. Antimicrob Agents Chemother. 2015;59(5):2765–73.CrossRefGoogle Scholar
  17. 17.
    Bebko SP, Green DM, Awad SS. Effect of a preoperative decontamination protocol on surgical site infections in patients undergoing elective orthopedic surgery with hardware implantation. JAMA Surg. 2015;150(5):390–5.CrossRefGoogle Scholar
  18. 18.
    Rezapoor M, Nicholson T, Tabatabaee RM, Chen AF, Maltenfort MG, Parvizi J. Povidone-iodine-based solutions for decolonization of nasal Staphylococcus aureus: a randomized, prospective, placebo-controlled study. J Arthroplast. 2017;32(9):2815–9.CrossRefGoogle Scholar
  19. 19.
    Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101–14.CrossRefGoogle Scholar
  20. 20.
    Schweizer ML, Cullen JJ, Perencevich EN, Vaughan Sarrazin MS. Costs associated with surgical site infections in veterans affairs hospitals. JAMA Surg. 2014;149(6):575–81.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Daniel S. Urias
    • 1
  • Merin Varghese
    • 1
    • 2
  • Thomas Simunich
    • 1
  • Shawna Morrissey
    • 1
  • Russell Dumire
    • 1
  1. 1.Conemaugh Memorial Medical CenterJohnstownUSA
  2. 2.Philadelphia College of Osteopathic Medicine, GeorgiaSuwaneeUSA

Personalised recommendations